Arthritis & Rheumatology

Article	Citations
National Mortality Databases to Assess Disease Burden in Systemic Autoimmune Diseases: A Valuable Resource But With Limitations	969
No differences in myocardial perfusion between treatment‐naive, early rheumatoid arthritis patients and healthy controls	399
	202
Higher alcohol consumption was associated with greater incidence of total hip replacement due to hip osteoarthritis in a dose‐dependent manner in women: comment on the article by Marchand et al	178
The Evolving Role of the Rheumatology Practitioner in the Care of Immunocompromised Patients in the COVID‐19 Era	154
	153
In This Issue	128
Clinical Connections	114
Association of change in metabolic syndrome status with altered risk of incident gout: comment on the article by Eun et al	108
Clinical Connections	105
Systemic lupus erythematosus and atherosclerosis progression risk: comment on the article by Papazoglou et al.	102
Seronegative palindromic rheumatism: what are we talking about? Comment on the article by Yang et al	96
Using Mice to Model Human Osteoarthritis: Age, Biologic Sex, and Pain Matter	87
Clinical Images: Rice bodies in pseudogout	83
Reply	77
In This Issue	69
Gut Microbiome and Osteoarthritis: Insights From the Naturally Occurring Canine Model of Osteoarthritis	69
The Devil Is in the Detail: Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty	69
Interleukin‐13 Receptor α1–Mediated Signaling Regulates Age‐Associated/Autoimmune B Cell Expansion and Lupus Pathogenesis	68
CCL19‐Positive Lymph Node Stromal Cells Govern the Onset of Inflammatory Arthritis via Tropomyosin Receptor Kinase	68
Exposure to Occupational Inhalants and the Risk of Developing Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis	64
Role of Glutaminase 2 in Promoting CD4+ T Cell Production of Interleukin‐2 by Supporting Antioxidant Defense in Systemic Lupus Erythematosus	63
Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV‐154 in Adults With Glucocorticoid‐Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Tr	62
Knee Alignment Correction by High Tibial Osteotomy Reduces Symptoms and Synovial Inflammation in Knee Osteoarthritis Accompanied by Macrophage Phenotypic Change From M1 to M2	62
Sex Differences in B Cells From the Joints of Children With Oligoarticular Juvenile Idiopathic Arthritis	62

Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy	61
Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial	59
Reply	58
Clinical Connections	57
Endogenous Retroelement Activation is Implicated in Interferon‐α Production and Anti–Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis	56
Assessing the Immune Cell Subset and Genetic Mutations in Patients With Palindromic Rheumatism Seronegative for Rheumatoid Factor and Anti–Cyclic Citrullinated Peptide	56
The Impact of Nonsteroidal Anti‐Inflammatory Drugs on Radiographic Spinal Progression in Patients With Axial Spondyloarthritis: 10‐Year Results From an Inception Cohort	55
Correction to “Novel Genetic Loci in Early‐Onset Gout Derived From Whole‐Genome Sequencing of an Adolescent Gout Cohort”	55
NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2‐Mediated Pyroptosis Through the Phosphorylated Salt‐Inducible Kinase 1/Sterol Regulatory Element Binding T	55
Minimal tofacitinib dose for maintenance in axial spondyloarthritis: real‐world data from a resource‐limited setting	55
A Metabolomic Signature Predicts Gout Flare Clinical Outcome Associated With Colchicine Prophylaxis	54
Disturbed Spatial WNT Activation—A Potential Driver of the Reticularized Skin Phenotype in Systemic Sclerosis	52
A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis	52
Single‐Cell Analysis Reveals Peripheral Helper T Cells in Rheumatoid Arthritis–Related Interstitial Lung Disease	52
In This Issue	50
At the Heart of Treating Kawasaki Disease: The Search for New Approaches to Prevent Coronary Artery Aneurysms	50
Successful Spontaneous Pregnancies and Healthy Neonates After Dual‐Target CAR –T Cell Therapy in Systemic Lupus Erythematosus	50
Distinct Natural Killer Cell Signature in Still Disease: Insights From a Multinational Immunome Project Consortium for Autoinflammatory Disorders	49
TWIST1 ‐Mediated Induction of AEBP1 in Fibroblast‐Like Synoviocytes Activates Transforming Growth Factor β Signaling t	48
Reply	47
Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool (PRESTO): A Step Towards Prevention	47
In Synergy With Interferon‐γ, Interleukin‐17 Activates Vascular Stromal Cells Toward a Proinflammatory Profile in Giant Cell Arteritis	46
A methodologic problem and a conceptual issue related to the new 2022 antineutrophil cytoplasmic antibody–related vasculitis criteria sets: comment on criteria sets approved by the American College of	46
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases	46
Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis	46
Efficacy and Safety of ABBV‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with Moderate‐to‐Severe Rheumatoid Arthr	45
Long‐Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis	45
Alteration of Gut Microbiota in Individuals at High‐Risk for Rheumatoid Arthritis Associated With Disturbed Metabolome and the Initiation of Arthritis Through the Triggering of Mucosal Immu	44
Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population‐Based Study Over Four Decades Using the Lupus Midwest Network	44
Revisiting the Ethics of Urate‐Lowering Therapy Clinical Trials for Gout Management	43
Variability of Primary Sjögren's Syndrome Is Driven by Interferon‐α and Interferon‐α Blood Levels Are Associated With the Class II HLA–DQ Locus	43
Reply	43
Critical Role of Notch‐1 in Mechanistic Target of Rapamycin Hyperactivity and Vascular Inflammation in Patients With Takayasu Arteritis	43
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria	43
Coverage Generosity of Novel Antirheumatic Drugs in Medicare Advantage and Stand‐Alone Part D Plans	42
Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib	42
Target trial emulation and cardiovascular safety inference in gout: comment on the article by Yokose et al.	41
Reply	40
Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis–Associated Lymphoproliferative Disorders	40
Hypoxia Promotes the Expression of ADAM9 by Tubular Epithelial Cells, Which Enhances Transforming Growth Factor β1 Activation and Promotes Tissue Fibrosis in Patients With Lupus Nephritis	40
Reply	39
Using Two Predictive Models to Capture Two Types of Poor Outcomes in Knee Arthroplasty: A Multisite Longitudinal Cohort Study	39
Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation: An Early Remission Induction Study	39
	38
In This Issue	38
Development and External Validation of a Model Predicting New‐Onset Chronic Uveitis at Different Disease Durations in Juvenile Idiopathic Arthritis	37
Journal Club	37
Journal Club	37
Clinical Image: Nasal rim sign: A clinical manifestation of dermatomyositis	37
Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits	37

Clinical Connections	37
	37
Role of autoantibodies in lupus nephritis: comment on the article by Fava et al	36
Not Only Excruciating Pain: Might a Gout Flare Episode Lead to Pulmonary Embolism?	36
Reply	36
Issue Information	36
Journal Club	36
Immediate Open Access: The Good, the Bad, and the Impact on Academic Society Publishing	36
	35
Revisiting the Synovium as a Structural Correlate of Pain in Osteoarthritis	34
Reply	34
Reply	34
The 2024 Vasculitis Foundation Quality Care Summit: Seeking Strategies to Improve Care for All Patients	34
Oxidative Stress by the Mitochondrial Monoamine Oxidase B Mediates Calcium Pyrophosphate Crystal–Induced Arthritis	33
Effects of Secukinumab on Enthesiophyte and Erosion Progression in Psoriatic Arthritis: A One‐Year Double‐Blind, Randomized, Placebo‐Controlled Trial Using High‐Resolution Peripheral Quantitative Comp	33
First‐Year IgG Dynamics in IgG4 ‐Related Disease: A Critical Window for Predicting Long‐Term Outco	33
Longitudinal Analysis of Somatic Mosaicism and Clonal Hematopoiesis in Cryopyrin‐Associated Periodic Syndrome	33
Superiority of Low‐Dose Benzbromarone to Low‐Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion	32
Vertebral Bone Mineral Density, Vertebral Strength, and Syndesmophyte Growth in Ankylosing Spondylitis: The Importance of Bridging	32
Abstract Supplement ACR Convergence 2025	32
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head‐to‐Head Randomized Phase IIIb<	32
Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome	31
Proteomic Profiling of the Large‐Vessel Vasculitis Spectrum Identifying Shared Signatures of Innate Immune Activation and Stromal Remodeling	31
Clinical Images: A painful bipartite patella	31
Identification of Novel Noncoding Genetic Variants of Serum Urate Using Whole‐Genome Sequencing in 7,339 Chinese Participants	31
Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis	31
Clinical Images: Increased bone metabolism in secondary hyperparathyroidism	30
	30
Journal Club	30
Reply	30
Lysosome‐Associated Membrane Protein 3 Induces Lysosome‐Dependent Cell Death by Impairing Autophagic Caspase 8 Degradation in the Salivary Glands of Individuals With Sjögren's Di	30
An investigation of the relationship between weight management and gout: insights from the THIN database study and recommendations for improvement. Comment on the article by Wei et al	30
Effects of Anti–Tumor Necrosis Factor Therapy on Osteoblastic Activity at Sites of Inflammatory and Structural Lesions in Radiographic Axial Spondyloarthritis: A Prospective Proof‐of‐Concept	30
Reply	29
Serologic Biomarkers of Progression Toward Diagnosis of Rheumatoid Arthritis in Active Component Military Personnel	29
In This Issue	29
In This Issue	29
The genetic contribution of inflammation to the increased risk of cardiovascular disease in rheumatoid arthritis: comment on the article by Yuan et al	29
Reply	29
Reply	29
Clinical Images: Burton line and scar hyperpigmentation in a patient with severe lead poisoning and saturnine gout	28
Hydroxychloroquine dose after hospitalization for systemic lupus erythematosus: comment on the article by Nestor et al	28
Reply	28
Doctor versus artificial intelligence: patient and physician evaluation of large language model responses to rheumatology patient questions: comment on the article by Ye et al	28
In This Issue	27
2025 American College of Rheumatology ( ACR ) Guideline for the Treatment of Systemic Lupus Erythematosus	27
Clinical images: VEXAS syndrome presenting as treatment‐refractory polyarteritis nodosa	27
Issue Information ‐ General Info	27
Programmed Death Ligand 1–Expressing Macrophages and Their Protective Role in the Joint During Arthritis	27
Heightened Proinflammatory Glycosylation of Borrelia burgdorferi IgG Antibodies in Synovial Fluid in Patients With Antibiotic‐Refractory Lyme Arthritis	27
Global burden of osteoarthritis attributable to high body mass index, 1990 to 2021: insights from the Global Burden of Disease study 2021: comment on the article by Lu et al	27
Corrigendum	27
Changes in Descending Pain Modulation During Anti–Tumor Necrosis Factor Therapy: A Prospective Study in Rheumatoid Arthritis and Spondyloarthritis	27
Clinical Connections	27
Clinical Image: Esophageal dilation and stenosis in systemic sclerosis	27
Trends in New Use of Disease‐Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022	27
Artificial Intelligence and Deep Learning for Rheumatologists	27
Role of Human Mesenchymal Stem Cells and Derived Extracellular Vesicles in Reducing Sensory Neuron Hyperexcitability and Pain Behaviors in Murine Osteoarthritis	27
Single‐Cell Level Characterization of B Cell Depletion and Repopulation Following Rituximab in Systemic Lupus Erythematosus	26
Clinical Images: Transient perivascular inflammation of the carotid artery syndrome	26
Nationwide Trends in Medication Use and Adverse Outcomes in Lupus Pregnancies: Progress and Persistent Gaps	26
Mucosal‐Associated Invariant T Cells in Rheumatic Diseases	26
Choosing to End African American Health Disparities in Patients With Systemic Lupus Erythematosus	26
Skin Transcriptomics Reveal Shared Molecular Mechanisms for Skin and Lung Involvement in Systemic Sclerosis	26
ZBTB20 Regulating Postnatal Articular Cartilage Development and Homeostasis: Implications for Early‐Onset Osteoarthritis	26
Biosimilar Competition for Humira Is Here: Signs of Hope Despite Early Hiccups	26
From GWAS Signal to Mechanism in Rheumatoid Arthritis: Lessons from a Single Risk Locus	25
Clinical Images: Biopsy‐proven hydroxychloroquine‐induced cardiomyopathy in an adolescent with systemic lupus erythematosus	25
The Efficacy of Short‐Term Bridging Strategies With High‐ and Low‐Dose Prednisolone on Radiographic and Clinical Outcomes in Active Early Rheumatoid Arthritis: A Double‐Blin	25
18F‐Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment within a Randomized Controlled Trial in Giant Cell Arteritis	25
A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis	25
DNA Methylation Profiling Reveals Distinct Epigenetic Clusters and Suggests Epigenetic Patterns Associated With Sex and Disease Activity in Childhood‐Onset Lupus	25
Screening of Environmental Chemicals to Characterize Exposures in Participants With Systemic Lupus Erythematosus	24
EAT ‐Lancet Diet Modifies the Risk of Rheumatoid Arthritis Through Metabolomic Signature	24
Strength Training is Associated With Less Knee Osteoarthritis: Data From the Osteoarthritis Initiative: Comment on the Article by Lo et al	24
Issue Information	24
Effect of Time to Start of Biologic Therapy on Treatment Response in Childhood Arthritis: Results From the UCAN CAN ‐ DU	24
A Risk Score to Detect Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease	24
	24
EULAR /American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis	24

Serum Urate–Lowering Efficacy and Safety of Tigulixostat in Gout Patients With Hyperuricemia: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Finding Trial	24
A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis	24
Higher complement C4 gene copy number constitutes a shared genetic risk factor for giant cell arte	24
Journal Club	24
Journal Club	23
Transforming Rheumatology Practice With Technology: Products, Processes, People, and Purpose	23
Clinical images: Huriez syndrome, a rare scleroderma mimic	23
Clinical Connections	23
Reply	23
Reply	23
Should lipoprotein(a) be routinely measured after COVID‐19? Comment on the article by Stahl et al	23
Reply	23
Addressing readability of online patient materials: comment on the American College of Rheumatology online information pages for patients and caregivers	23
Reply	23
ADAM9 Promotes Glycolysis in Th17 Cells and Autoimmunity Through Activation of IGF ‐1 Signaling	22
Retraction	22
Circulating interferon alpha protein measured with digital enzyme‐linked immunosorbent assay as a biomarker for modified Rodnan skin score progression in limited systemic sclerosis: comment on the art	22
Local Ancestry at the Major Histocompatibility Complex Region is Not a Major Contributor to Disease Heterogeneity in a Multiethnic Lupus Cohort	22
Autoantigen Peptide‐8‐Arm Polyethylene Glycol‐Dyes Specifically Recognize Antigen‐Specific B Cells and Improve the Diagnosis of Rheumatoid Arthritis	22
Erratum	22
List of Reviewers	22
Systemic autoimmune rheumatic disease risk is associated with long‐term exposure to fine particulate matter: comment on the article by Geslin et al	22
The Transition From Residency to Fellowship: Enhancing Training by Increasing Transparency	22
Association of 18F‐Fluorodeoxyglucose–Positron Emission Tomography Activity With Angiographic Progression of Disease in Large Vessel Vasculitis	22
Short‐term risk of cardiovascular events in people newly diagnosed with gout: comment on the article by Cipolletta et al	22
Weight Reduction and Target Serum Urate Level: A Longitudinal Study of Annual Medical Examination	22
Cartilage Acidic Protein 1 in Plasma Associates With Prevalent Osteoarthritis and Predicts Future Risk as Well as Progression to Joint Replacements: Results From the UK Biobank Resource	22
Promotion of Joint Degeneration and Chondrocyte Metabolic Dysfunction by Excessive Growth Hormone in Mice	21
Increased risk of statin‐associated autoimmune myopathy among American Indians	21
Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients With Amyopathic Dermatomyositis With Interstitial Lung Disease	21
Drug‐Induced Raynaud's Phenomenon and Underlying Mechanism: A Disproportionality Analysis From the World Health Organization Pharmacovigilance Database	21
Hand Swelling and Other Non–Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US	21
Differences in IgG Sialylation Distinguish Asymptomatic From Symptomatic Antinuclear Antibody–Positive Individuals	21
Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c + Dendritic Cell Dysregul	21
Effective performance of the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for Antineutrophil‐Cytoplasmic‐Antibody‐Associated Vasculi	21
Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients With Systemic Lupus Erythematosus and Comor	21
Genome‐Wide Association Study Identifies the First Germline Genetic Variant Associated With Erdheim‐Chester Disease	21
WITHDRAWAL: Associations and Diagnostic Accuracy of Ultrasound Features in Knee Osteoarthritis: Comment on the Article by Yates KA et al.	21
Immunologic Profiling Suggests an Association Between Treg Cell Dysfunction and Pain in Knee Osteoarthritis	21
Treatment of a Large Cohort of Childhood Chronic Noninfectious Uveitis in a Multicentric Large Study: Adalimumab Versus Methotrexate as First‐Line Therapy	21
Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis–Associated Interstitial Lung Disease	20
Journal Club	20
Plasma Proteomic Profiles Predict Individual Future Osteoarthritis Risk	20
Complement	20
The oral microbiota in persons at risk for rheumatoid arthritis: follow‐up data for the article by Kroese et al	20
Mapping and Analysis of Protein and Gene Profile Identification of the Important Role of Transforming Growth Factor Beta in Synovial Invasion in Patients With Pigmented Villonodular Synovitis	20
Critical Role for Transglutaminase 2 in Scleroderma Skin Fibrosis and in the Development of Dermal Sclerosis in a Mouse Model of Scleroderma	20
Skeletal Muscle Composition, Power, and Mitochondrial Energetics in Older Men and Women With Knee Osteoarthritis	20
Concordance between ultrasound and physical examination in enthesitis assessment: a call for further investigation: comment on the article by Di Matteo et al	20
How do interleukin‐33 and neutrophil extracellular traps cooperate to induce epithelial‐mesenchymal transition in alveolar epithelial cells?	20
Association of Autoantibody Concentrations and Trajectories With Lupus Nephritis Histologic Features and Treatment Response	20
Effects of B Cell Depletion by CD19‐Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis	20
In This Issue	19
Issue Information	19
Correspondence and comments on American College of Rheumatology and EULAR antiphospholipid syndrome classification criteria: comment on the article by Barbhaiya et al	19
The effect of air pollution and genetic susceptibility on systemic lupus erythematosus: comment on the article by Xing et al	19
Clinical Connections	19
Do We Need More Exercise and Osteoarthritis Randomized Clinical Trials?	19
Reply	19
Clinical Images: Erdheim‐Chester disease presenting with palpitations and spondylopathy	19
Clinical Trials in Systemic Sclerosis: Crossroads and Opportunities	18
Clinical Connections	18
Journal Club	18
Reply	18
Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Proteinase 3–Antineutrophil Cytoplasmic Antibody Vasculitides	18
Peripheral γδ T Cells Regulate Neutrophil Expansion and Recruitment in Experimental Psoriatic Arthritis	18
Phenotype Risk Score but Not Genetic Risk Score Aids in Identifying Individuals With Systemic Lupus Erythematosus in the Electronic Health Record	18
Risk of arrhythmia among new users of hydroxychloroquine: comment on the article by Hoque et al	18
Association of alcohol consumption with disease activity and health‐related quality of life in rheumatoid arthritis: comment on the article by Alfredsson et al	18
Risk of serious infection between belimumab and oral immunosuppressants for non‐renal systemic lupus erythematosus: comment on the article by Materne et al	18
Associations Between Changes in Pain Sensitization and Disease Activity Following Disease‐Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis	18
Long‐Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor–Associated Periodic Syndrome: Results From a Phase III Trial	18
Some More Equal Than Others: The Divergence of Cardiac Risk in the Use of Nonsteroidal Anti‐Inflammatory Drugs Versus Colchicine for Treating and Preventing Gout	18
The Characteristics of Patients With COVID‐19–Associated Pediatric Vasculitis: An International, Multicenter Study	18
Clinical Connections	18
Weighing the Cardiovascular Risks of Low‐Dose Glucocorticoids in Rheumatoid Arthritis From Real‐World Data	18
	18
Should Low Serum Urate Be Exonerated? Untangling the Influence of Sarcopenia in Observational Studies	18
ChatGPT, et al…Artificial Intelligence, Authorship, and Medical Publishing	18
Diversity and Epitope Spreading of Anti–RNA Polymerase III Antibodies in Systemic Sclerosis: A Potential Biomarker for Skin and Lung Involvement	18
Expert Perspective: Hematologic Malignancies and Vasculitis	18
Gout and Excess Risk of Severe SARS–CoV‐2 Infection Among Vaccinated Individuals: A General Population Study	18
Association of Clonal Hematopoiesis With Incident, Late‐Onset, Seropositive Rheumatoid Arthritis	17
Transition From Psoriasis to Psoriatic Arthritis is Characterized by Distinct Alterations in Peripheral Blood Tc17, Th17, and CD4 +	17
Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis With Polyangiitis: Findings From a Large European Cohort	17
Autoantibodies to Joint‐Related Peptides Are Associated with Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals	17
Increased Diagnostic Accuracy of the Labial Gland Biopsy in Primary Sjögren Syndrome When Multiple Histopathological Features Are Included	17
A Novel Human Interleukin‐23A Overexpressing Mouse Model of Systemic Lupus Erythematosus	17
Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data	17
Identification of Novel Loci Shared by Juvenile Idiopathic Arthritis Subtypes Through Integrative Genetic Analysis	17
Genetics of Childhood‐Onset Systemic Lupus Erythematosus	17
Reply	16
Serious Infections in Offspring Exposed to Tumor Necrosis Factor Inhibitors During Pregnancy: Comparison of Timing During Pregnancy and Placental Transfer Ability	16
Duloxetine and osteoarthritis, a herd of elephants in the room: comment on the article by van den Driest et al	16
Superiority of low‐dose benzbromarone to low‐dose febuxostat in gout patients with renal uric acid underexcretion: comment on the article by Yan et al	16